New Target in Sickle Cell Disease

Welcome to the first in a series of case studies illustrating how metabolomics can help you unlock your biomarker discovery program. These will showcase Metabolon clients’ achievements in discovery, preclinical, and clinical research.

In this example, our client leveraged metabolomics insights to reveal an unknown pathway and a promising target for a new drug.